Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 27, 2015
Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastagingSimon Lavotshkin, John R Jalas, Hitoe Torisu-Itakura, et al.
Head & Neck|October 23, 2020
Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection marginsLauren Hum, Daniel Bethmann, Zipei Feng, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Frontiers in Medicine|April 20, 2026
NTRK fusions and concomitant immune and genomic landscape detected by DNA and RNA comprehensive genomic profiling in a large healthcare systemAlexa K Dowdell, Thomas R Ward, Lauren T Hamilton, et al.
Journal of Clinical and Translational Science|June 30, 2021
Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivityJeffrey S Smith, Haley Hanseler, John Welle, et al.
JCO Oncology Practice|November 12, 2024
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health SystemAlexa K Dowdell, Ryan C Meng, Ann Vita, et al.
Cancer Cell|April 12, 2022
Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancersChunhong Zheng, Joseph N Fass, Yi-Ping Shih, et al.
Clinical & Experimental Metastasis|May 10, 2021
Cancer microenvironment and genomics: evolution in processStanley P Leong, Isaac P Witz, Orit Sagi-Assif, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
Pageof 3